Bio-equivalence Study Between SAPHRIS and Asenapine

Clinical trial NCT01948024 · COMPLETED

Trial details

NCT number: NCT01948024
Sponsor: Sun Pharmaceutical Industries Limited
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Schizophrenia Bipolar Disorder

Start date: 2013-07-01
Primary completion: 2013-08-01
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.